HomeCompareRMD vs MCO

RMD vs MCO: Dividend Comparison 2026

RMD yields 1.06% · MCO yields 0.89%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCO wins by $175.5K in total portfolio value
10 years
RMD
RMD
● Live price
1.06%
Share price
$220.03
Annual div
$2.33
5Y div CAGR
35.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.7K
Annual income
$3,288.25
Full RMD calculator →
MCO
MCO
● Live price
0.89%
Share price
$432.05
Annual div
$3.85
5Y div CAGR
74.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$207.2K
Annual income
$113,279.94
Full MCO calculator →

Portfolio growth — RMD vs MCO

📍 MCO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRMDMCO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RMD + MCO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RMD pays
MCO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RMD
Annual income on $10K today (after 15% tax)
$90.01/yr
After 10yr DRIP, annual income (after tax)
$2,795.01/yr
MCO
Annual income on $10K today (after 15% tax)
$75.74/yr
After 10yr DRIP, annual income (after tax)
$96,287.95/yr
At 15% tax rate, MCO beats the other by $93,492.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RMD + MCO for your $10,000?

RMD: 50%MCO: 50%
100% MCO50/50100% RMD
Portfolio after 10yr
$119.4K
Annual income
$58,284.09/yr
Blended yield
48.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCO right now

RMD
Analyst Ratings
16
Buy
14
Hold
5
Sell
Consensus: Buy
Price Target
$295.88
+34.5% upside vs current
Range: $265.00 — $345.00
Altman Z
11.6
Piotroski
7/9
MCO
Analyst Ratings
18
Buy
13
Hold
1
Sell
Consensus: Buy
Price Target
$543.08
+25.7% upside vs current
Range: $480.00 — $620.00
Altman Z
5.3
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RMD buys
0
MCO buys
7
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$MCO▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MCO▼ Sell$1,001 - $15,0002025-09-23
Lisa McClain🏢 House$MCO▼ Sell$1,001 - $15,0002025-06-11
Lisa McClain🏢 House$MCO▼ Sell$1,001 - $15,0002025-06-10
Dan Newhouse🏢 House$MCO▼ Sell$1,001 - $15,0002025-04-11
Lisa McClain🏢 House$MCO▲ Buy$1,001 - $15,0002024-12-11
Valerie Hoyle🏢 House$MCO▲ Buy$1,001 - $15,0002024-10-29
Tommy Tuberville🏛 Senate$MCO▼ Sell$1,001 - $15,0002024-05-03
Ro Khanna🏢 House$MCO▲ Buy$1,001 - $15,0002024-01-10
Ro Khanna🏢 House$MCO▲ Buy$15,001 - $50,0002023-10-31
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRMDMCO
Forward yield1.06%0.89%
Annual dividend / share$2.33$3.85
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR35.9%74.8%
Portfolio after 10y$31.7K$207.2K
Annual income after 10y$3,288.25$113,279.94
Total dividends collected$10.4K$178.5K
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusBuyBuy
Analyst price target$295.88$543.08

Year-by-year: RMD vs MCO ($10,000, DRIP)

YearRMD PortfolioRMD Income/yrMCO PortfolioMCO Income/yrGap
1← crossover$10,844$143.91$10,856$155.76$12.00MCO
2$11,801$198.21$11,892$276.24$91.00MCO
3$12,901$273.96$13,219$494.35$318.00MCO
4$14,185$380.39$15,042$897.70$857.00MCO
5$15,709$531.20$17,763$1,668.77$2.1KMCO
6$17,556$747.16$22,226$3,219.45$4.7KMCO
7$19,845$1,060.53$30,363$6,580.83$10.5KMCO
8$22,757$1,522.63$47,175$14,686.41$24.4KMCO
9$26,567$2,217.64$87,754$37,276.83$61.2KMCO
10$31,715$3,288.25$207,177$113,279.94$175.5KMCO

RMD vs MCO: Complete Analysis 2026

RMDHealthcare

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Full RMD Calculator →

MCOFinancials

Moody's Corporation operates as an integrated risk assessment firm worldwide. It operates in two segments, Moody's Investors Service and Moody's Analytics. The Moody's Investors Service segment publishes credit ratings and provides assessment services on various debt obligations, programs and facilities, and entities that issue such obligations, such as various corporate, financial institution, and governmental obligations, as well as and structured finance securities. This segment provides ratings in approximately 140 countries. Its ratings are disseminated through press releases to the public through electronic media, including the internet and real-time information systems used by securities traders and investors. This segment has rated approximately 5,000 non-financial corporates; 3,600 financial institutions; 16,000 public finance issuers; 145 sovereigns; 47 supranational institutions; 459 sub-sovereigns; and 1,000 infrastructure and project finance issuers, as well as 9,100 structured finance deals. The Moody's Analytics segment develops a range of products and services that support the risk management activities of institutional participants in financial markets; and offers subscription based research, data, and analytical products comprising credit ratings, credit research, quantitative credit scores and other analytical tools, economic research and forecasts, business intelligence and company information products, commercial real estate data and analytical tools, and on-line and classroom-based training services, as well as credentialing and certification services. It also offers offshore analytical and research services with learning solutions and certification programs; and software solutions, as well as related risk management services. The company was formerly known as Dun and Bradstreet Company and changed its name to Moody's Corporation in September 2000. Moody's Corporation was founded in 1900 and is headquartered in New York, New York.

Full MCO Calculator →
📬

Get this RMD vs MCO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RMD vs SCHDRMD vs JEPIRMD vs ORMD vs KORMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.